Sign In
Buy BCLI
$0.770
-0.0217 (-2.74%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
5 Stock Gainers for Thursday: Smith & Wesson, Calix, Sunopta
08:36pm, Thursday, 23'rd Jul 2020
Smith & Wesson Brands, Calix, Sunopta, eXp Realty, and Vivent Solar are some of Thursday's movers.
Longtime IIA CEO Richard Chambers plans to step down in March
12:20pm, Thursday, 23'rd Jul 2020
Richard Chambers, who has led the Institute of Internal Auditors for 12 years, will be stepping down effective March 31, 2021. The IIA plans to begin an immediate search for a new CEO.
BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS
11:00am, Thursday, 23'rd Jul 2020
Graph A quantitative analysis for Acute Lung Injury was performed using a severity scoring scale, showed a significant reduction in the severity of lung injury in Nurown exosomes group as compare to c
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
Insider Weekends: Andrew Spodek Purchases $1 Million Worth Of Postal Realty Trust
11:52am, Monday, 20'th Jul 2020
Insider buying increased last week. Notable Insider Buys: Postal Realty Trust, Inc., Avid Technology, Inc., Brainstorm Cell Therapeutics Inc., Perspecta Inc., and AZZ Inc.
BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share…
01:10pm, Thursday, 09'th Jul 2020
By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update KOL Event for Alzheimer’s Program On July 8, 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) conducted a Key
IIA, IFAC urge audit committees to address coronavirus risks
06:54pm, Wednesday, 08'th Jul 2020
The Institute of Internal Auditors and the International Federation of Accountants are calling on audit committees to be vigilant about risk management, performance, controls and processes during the
BrainStorm Hosting KOL Webinar to Discuss NurOwn® Phase 2 Alzheimer's Disease Program
09:31am, Wednesday, 08'th Jul 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, is hosting a Key Opinion Leader (KOL) webinar on its Alzheimer's Dise
Lineage Cell Therapeutics Announces Extension of OpRegen® Development Grant From Israel Innovation Authority
12:00am, Monday, 06'th Jul 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medic
Stocks To Watch: Postmates, Walgreens And Cannabis Plays
08:17am, Saturday, 04'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS
10:49am, Thursday, 02'nd Jul 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that final participant dosing has been administered i
BrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL Webinar
12:50pm, Wednesday, 01'st Jul 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, will hold a Key Opinion Leader (KOL) webinar on the Company's Alzheim
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that addre
